{"DataElement":{"publicId":"3431313","version":"1","preferredName":"Cervical Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cervical cancer.","longName":"3431296v1.0:3431282v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3431296","version":"1","preferredName":"Cervical Cancer Stage Grouping","preferredDefinition":"Relating to a neck, or cervix, in any sense._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2434808v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2434808","version":"1","preferredName":"Cervical Neoplasm","preferredDefinition":"Relating to a neck, or cervix, in any sense.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12844:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical","conceptCode":"C12844","definition":"Relating to a neck, or cervix, in any sense.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0643AECC-B6B2-298D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-30","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-30","modifiedBy":"ONEDATA","dateModified":"2005-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDEF3E0-01F1-67A7-E040-BB89AD437539","latestVersionIndicator":"No","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"TAYLORT","dateModified":"2017-10-10","changeDescription":"10/10/17 tt Transferred ownership/BC. Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3431282","version":"1","preferredName":"Cervical Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A finding about one or more characteristics of cervical cancer, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3431282v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-654C-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB Cervical Cancer","ValueMeaning":{"publicId":"2974248","version":"1","preferredName":"Stage IVB Cervical Cancer","longName":"2974248","preferredDefinition":"Stage IVB includes: Any T, Any N, MI. M1: Distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Cervical Cancer AJCC v6 and v7","conceptCode":"C6324","definition":"Stage IVB includes: Any T, Any N, MI. M1: Distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1E891-8E8E-8DA1-E040-BB89AD4354E9","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-12-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-6560-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Cervical Cancer","ValueMeaning":{"publicId":"3431283","version":"1","preferredName":"Stage IVA Cervical Cancer","longName":"3431283","preferredDefinition":"Stage IVA includes: T4, Any N, M0). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Cervical Cancer AJCC v6 and v7","conceptCode":"C6323","definition":"Stage IVA includes: T4, Any N, M0). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-656B-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-6583-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Cervical Cancer","ValueMeaning":{"publicId":"3431284","version":"1","preferredName":"Stage IIIB Cervical Cancer","longName":"3431284","preferredDefinition":"Stage IIIB includes: (T3b, Any N, M0); (T1-3, N1, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and7th eds.) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Cervical Cancer AJCC v6 and v7","conceptCode":"C6321","definition":"Stage IIIB includes: (T3b, Any N, M0); (T1-3, N1, M0).  T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-658E-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-65A6-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Cervical Cancer","ValueMeaning":{"publicId":"3431285","version":"1","preferredName":"Stage IIIA Cervical Cancer","longName":"3431285","preferredDefinition":"Stage IIIA includes: T3a, N0, M0. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Cervical Cancer AJCC v6 and v7","conceptCode":"C6322","definition":"Stage IIIA includes: T3a, N0, M0.  T3a: Tumor involves lower third of vagina, no extension to pelvic wall.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-65B1-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-65C9-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Cervical Cancer","ValueMeaning":{"publicId":"2838733","version":"1","preferredName":"Stage III Cervical Cancer","longName":"2838733","preferredDefinition":"Stage III includes: III (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T1, N1, M0), (T2, N1, M0), (T3a, N1, M0), (T3b, Any N, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Cervical Cancer AJCC v6 and v7","conceptCode":"C9205","definition":"Stage III includes: III (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T1, N1, M0), (T2, N1, M0), (T3a, N1, M0), (T3b, Any N, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3a: Tumor involves lower third of vagina, no extension to pelvic wall.  T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non functioning kidney.  N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1081-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-65D4-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Cervical Cancer","ValueMeaning":{"publicId":"3431286","version":"1","preferredName":"Stage IIB Cervical Cancer","longName":"3431286","preferredDefinition":"Stage IIB includes: T2b, N0, M0. T2b: Tumor with parametrial invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Cervical Cancer AJCC v6 and v7","conceptCode":"C6320","definition":"Stage IIB includes: T2b, N0, M0.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-65DE-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-65F6-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IIA2","valueDescription":"Stage IIA2 Cervical Cancer","ValueMeaning":{"publicId":"3431287","version":"1","preferredName":"Stage IIA2 Cervical Cancer","longName":"3431287","preferredDefinition":"Stage IIA2 includes: T2a2, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA2 Cervical Cancer AJCC v7","conceptCode":"C95173","definition":"Stage IIA2 includes: T2a2, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-6603-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-661C-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IIA1","valueDescription":"Stage IIA1 Cervical Cancer","ValueMeaning":{"publicId":"3431288","version":"1","preferredName":"Stage IIA1 Cervical Cancer","longName":"3431288","preferredDefinition":"Stage IIA1 includes: T2a1, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA1 Cervical Cancer AJCC v7","conceptCode":"C95172","definition":"Stage IIA1 includes: T2a1, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-6628-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-6641-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Cervical Cancer","ValueMeaning":{"publicId":"3431289","version":"1","preferredName":"Stage IIA Cervical Cancer","longName":"3431289","preferredDefinition":"Stage IIA includes: IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0). T2a: Tumor without parametrial invasion. T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension. T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Cervical Cancer AJCC v7","conceptCode":"C89552","definition":"Stage IIA includes: IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0).  T2a: Tumor without parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-664B-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-6663-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Cervical Cancer","ValueMeaning":{"publicId":"2838729","version":"1","preferredName":"Stage II Cervical Cancer","longName":"2838729","preferredDefinition":"Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but no to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion. T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension. T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension. T2b: Tumor with parametrial invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Cervical Cancer AJCC v7","conceptCode":"C89551","definition":"Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1035-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-666E-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IB2","valueDescription":"Stage IB2 Cervical Cancer","ValueMeaning":{"publicId":"3179331","version":"1","preferredName":"Stage IB2 Cervical Cancer","longName":"3179331","preferredDefinition":"Stage IB2 includes: T1b2, N0, M0. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB2 Cervical Cancer AJCC v6 and v7","conceptCode":"C6318","definition":"Stage IB2 includes: T1b2, N0, M0.  T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F82D-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-6682-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IB1","valueDescription":"Stage IB1 Cervical Cancer","ValueMeaning":{"publicId":"3179332","version":"1","preferredName":"Stage IB1 Cervical Cancer","longName":"3179332","preferredDefinition":"Stage IB1 includes: T1b1, N0, M0. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB1 Cervical Cancer AJCC v6 and v7","conceptCode":"C6317","definition":"Stage IB1 includes: T1b1, N0, M0.  T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F850-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-6697-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Cervical Cancer","ValueMeaning":{"publicId":"3431290","version":"1","preferredName":"Stage IB Cervical Cancer","longName":"3431290","preferredDefinition":"Stage IB includes: IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Cervical Cancer AJCC v6 and v7","conceptCode":"C6316","definition":"Stage IB includes: IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-66A2-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-66BA-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IA2","valueDescription":"Stage IA2 Cervical Cancer","ValueMeaning":{"publicId":"3179334","version":"1","preferredName":"Stage IA2 Cervical Cancer","longName":"3179334","preferredDefinition":"Stage IA2 includes: T1a2, N0, M0. T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA2 Cervical Cancer AJCC v6 and v7","conceptCode":"C6315","definition":"Stage IA2 includes: T1a2, N0, M0.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F895-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-66CF-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IA1","valueDescription":"Stage IA1 Cervical Cancer","ValueMeaning":{"publicId":"3179335","version":"1","preferredName":"Stage IA1 Cervical Cancer","longName":"3179335","preferredDefinition":"Stage IA1 includes: T1a1, N0, M0. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA1 Cervical Cancer AJCC v6 and v7","conceptCode":"C6314","definition":"Stage IA1 includes: T1a1, N0, M0.  T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F8B8-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-66E4-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Cervical Cancer","ValueMeaning":{"publicId":"3431291","version":"1","preferredName":"Stage IA Cervical Cancer","longName":"3431291","preferredDefinition":"Stage IA includes: IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0). T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread. T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Cervical Cancer AJCC v6 and v7","conceptCode":"C6313","definition":"Stage IA includes: IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0).  T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-66EF-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-6707-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Cervical Cancer","ValueMeaning":{"publicId":"2838731","version":"1","preferredName":"Stage I Cervical Cancer","longName":"2838731","preferredDefinition":"Stage I includes: I (T1, N0, M0); IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0); IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1: Cervical carcinoma confined to uterus (extension to corpus should be disregarded). T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread. T1a2: Measured stromal invasion more than 3.0mm and not more than 5.0 mm with a horizontal spread 7.0mm or less. T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Cervical Cancer AJCC v6 and v7","conceptCode":"C9204","definition":"Stage I includes: I (T1, N0, M0); IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0); IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1: Cervical carcinoma confined to uterus (extension to corpus should be disregarded). T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread.  T1a2: Measured stromal invasion more than 3.0mm and not more than 5.0 mm with a horizontal spread 7.0mm or less. T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-105B-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-6712-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Cervical Cancer","ValueMeaning":{"publicId":"2838727","version":"1","preferredName":"Stage 0 Cervical Cancer","longName":"2838727","preferredDefinition":"Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Cervical Cancer AJCC v7","conceptCode":"C89550","definition":"Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis.  M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-100F-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCDE9F64-671C-D14C-E040-BB89AD43176F","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3431281","version":"1","preferredName":"Cervical Cancer TNM Finding v7 American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A finding about one or more characteristics of cervical cancer, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89477:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Cancer TNM Finding v7","conceptCode":"C89477","definition":"A finding about one or more characteristics of cervical cancer, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-6523-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-6534-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3434438","version":"1","longName":"Cervical","context":"NCIP"},{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5675515","version":"1","longName":"Cervix Uteri","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BCDFA017-8FB7-1FB5-E040-BB89AD4379D4","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}